icd 10 code for squamous cell carcinoma in situ icd 10 code for squamous cell carcinoma in situ

. 5th digit 1: Basal cell carcinoma of skin 5th digit 2: Squamous cell carcinoma of skin 5th digit 9: Other specific malignant neoplasm of skin : Kaposi Sarcoma (46) . There are multiple ways to create a PDF of a document that you are currently viewing. 2016 (effective 10/1/2015): New code (first year of non . The main histological types of NSCLC are adenocarcinoma, squamous cell and large cell carcinoma. hbbd```b``+A$S2Xd,@$k5XDO0y LlU@&0&y*&F`I 30,` VF You can collapse such groups by clicking on the group header to make navigation easier. Per the 2020 ICD-10 guidelines, 'consistent with D04.4 would be incorrect as this is documented neither [I]in situ [/I]nor as a carcinoma of the skin. preparation of this material, or the analysis of information provided in the material. Basal cell carcinoma of skin, unspecified. #2. due to the exclude 1 note you do not code the C50 code with the D05 code so code only the invasive. . Medicaid and the State Children's Health Insurance Programs, contracts with certain organizations to assist in the administration The 5th character is the sex code, while the 6th character is the laterality code. Note: . "JavaScript" disabled. It often arises within solar/ actinic keratosis or within squamous cell carcinoma in situ. Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, Instructions for enabling "JavaScript" can be found here. copied without the express written consent of the AHA. You, your employees and agents are authorized to use CPT only as agreed upon with the AMA internally within your organization within the United States for the sole use by yourself, employees and agents. Verrucous carcinoma is a type of squamous cell carcinoma (SCC) that can develop in your gums and cheeks the oral cavity as well as your genitals and feet. Please review and accept the agreements in order to view Medicare Coverage documents, which may include licensed information and codes. Risk factors for the disease are exposure to sun (specifically . My provider is documenting a squamous cell carcinoma in situ of the jaw, do I code this as C44.329 or D04.39 as the SCC and in situ are separate ICD-10 codes? article does not apply to that Bill Type. "JavaScript" disabled. Squamous cell carcinoma of the anus (C210) is reportable. The Medicare program provides limited benefits for outpatient prescription drugs. As used herein, "you" and "your" refer to you and any organization on behalf of which you are acting. Instructions for enabling "JavaScript" can be found here. Subscribe to Codify by AAPC and get the code details in a flash. 7500 Security Boulevard, Baltimore, MD 21244. The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient. The AMA does not directly or indirectly practice medicine or dispense medical services. _) Y New Term 8013/3 Combined large cell neuroendocrine carcinoma (C34. The Medicare program provides limited benefits for outpatient prescription drugs. Revenue Codes are equally subject to this coverage determination. Lady T:cool: [QUOTE="jh1991, post: 469112, member: 237375"] You can use the Contents side panel to help navigate the various sections. The Centers for Medicare 38 Medicaid Services CMS wants your comment on the FY 2018 Inpatient Prospective Payment System and Long Term Acute Care HospitalProposed RulebyJune 13 2017. Other risk factors for SCC include: To assign the most appropriate ICD-10-CM code for squamous cell carcinoma, clinical documentation should indicate: ICD-10-CM chapter 2 contains codes for most benign and malignant neoplasms. CPT codes, descriptions and other data only are copyright 2022 American Medical Association. THE UNITED STATES Refer to the LCD for reasonable and necessary requirements and limitations. All rights reserved. However, please note that once a group is collapsed, the browser Find function will not find codes in that group. Applicable FARS\DFARS Restrictions Apply to Government Use. Basal cell carcinoma of skin of nose. No fee schedules, basic unit, relative values or related listings are included in CPT. Histology of SCC Sometimes, a large group can make scrolling thru a document unwieldy. Leiomyosarcoma 88903; rare tumor arising in the muscle layer of the bladder. In accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice. Request a Demo 14 Day Free Trial Buy Now Official Long Descriptor and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only Articles often contain coding or other guidelines that are related to a Local Coverage Determination (LCD). Primary malignant neoplasms overlapping site boundaries. Your MCD session is currently set to expire in 5 minutes due to inactivity. descriptions may not be removed, copied, or utilized within any software, product, service, solution or derivative work Article document IDs begin with the letter "A" (e.g., A12345). Refer to the LCD for reasonable and necessary requirements and limitations. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. B5l2`4'l2_v n6M#~zx#d[mp1VXlu[1NWJu~@}Z~@R'h&\x$f$e" =ih9L|-U*|=LeXOs9"eY9j=IYRh{p "AYqn[sNxD!D>* Hqq0.DzXCX|P| VGi] kb$+%=IpzpTkk*. The submitted medical record must support the use of the selected ICD-10-CM code(s). Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT for resale and/or license, transferring copies of CDT to any party not bound by this agreement, creating any modified or derivative work of CDT, or making any commercial use of CDT. This is the American ICD-10-CM version of D04.9 - other international versions of ICD-10 D04.9 may differ. A federal government website managed and paid for by the U.S. Centers for Medicare & Medicaid Services. In men, lung . Primary malignant neoplasms overlapping site boundaries. Primary malignant neoplasms overlapping site boundaries. License to use CPT for any use not authorized herein must be obtained through the AMA, CPT Intellectual Property Services, AMA Plaza 330 N. Wabash Ave., Suite 39300, Chicago, IL 60611-5885. DISCLOSED HEREIN. If you are experiencing any technical issues related to the search, selecting the 'OK' button to reset the search data should resolve your issues. All Rights Reserved. If your session expires, you will lose all items in your basket and any active searches. The submitted CPT/HCPCS code must describe the service performed. All rights reserved. Complete absence of all Revenue Codes indicates that coverage is not influenced by Bill Type and the article should be assumed to Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. The medical record/progress note should indicate the removal of a malignant lesion with a corresponding pathology report or a clinical description consistent with a skin malignancy. C44.82 Squamous cell carcinoma of overlapping sites of skin The AMA assumes no liability for data contained or not contained herein. %%EOF C44.229 Squamous cell carcinoma of skin of left ear and external auricular canal Squamous Cell Carcinoma (SCC) 31 Coding of Neoplasms in ICD-10-CM A patient returns to the dermatologist to discuss removal of his SCC on his lower lip. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11640, 11641, 11642, 11643, 11644, and 11646. There are 90 terms under the parent term 'Carcinoma In Situ' in the ICD-10-CM Alphabetical Index . Cutaneous SCC is an invasive disease, referring to cancer cells that have grown beyond the epidermis. Bowen's disease: squamous cell carcinoma in situ Bowen's disease is a premalignant condition that clinically presents as an asymptomatic, scaly or crusted plaque on the skin. The submitted medical record must support the use of the selected ICD-10-CM code(s). Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes. Your MCD session is currently set to expire in 5 minutes due to inactivity. recipient email address(es) you enter. The program covers drugs that are furnished "incident-to" a physician's service provided that the drugs are not "usually self-administered" by the patient. CPT is a trademark of the American Medical Association (AMA). This treatment is often used for small or very superficial squamous cell cancers of the skin. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or you could code both and use the exclude 1 exception if documentation were to indicate invasive in one breast and in-situ in the other. The views and/or positions presented in the material do not necessarily represent the views of the AHA. License to use CPT for any use not authorized herein must be obtained through the AMA, CPT Intellectual Property Services, AMA Plaza 330 N. Wabash Ave., Suite 39300, Chicago, IL 60611-5885. Youll find a lot of suggestions and better answers to your question in the Member Forums. on Squamous Cell Carcinoma ICD-10-CM Coding, Tech & Innovation in Healthcare eNewsletter, Excision of Benign or Malignant Skin Lesion, Healthcare Finance Newsday: "AHIMA, AHA back move to ICD-10 as other groups cite high costs", AAPC to Host 17th Annual National Conference in Las Vegas in April 2009, Portability Issues Give PHRs a Rocky Start, Dome-shaped or crusty lesion that may bleed, Flat, reddish, scaly patch that grows slowly, Blue or green eyed people with blond or red hair, Long-term daily sun exposure, as with people that work outdoors with no sun protection or covering up, Older age. In accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Absence of a Bill Type does not guarantee that the 9: Squamous cell carcinoma of the anus, NOS Squamous cell carcinoma of the anus (C210) is reportable. Cutaneous squamous-cell carcinoma is the second most common skin cancer, accounting for over 1 million cases in the United States each year.. Thyroid []. 604 0 obj <> endobj You can use the Contents side panel to help navigate the various sections. Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license. 8 [QUOTE="thomas7331, post: 507729, member: 5404"] If your session expires, you will lose all items in your basket and any active searches. The codes for squamous cell carcinoma are under category C44 Other and unspecified malignant neoplasm of skin. Reproduced with permission. If you are acting on behalf of an organization, you represent that you are authorized to act on behalf of such organization and that your acceptance of the terms of this agreement creates a legally enforceable obligation of the organization. without the written consent of the AHA. The page could not be loaded. The Centers for Medicare 38 Medicaid Services CMS has identified four quality measures impacted by the Oct. 1 update to the ICD10CM code set. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816. Codes with a subcategory listing further specify laterality. All neoplasms are classified in this chapter, whether they are functionally active or not. CDT is a trademark of the ADA. When verrucous carcinoma forms in your mouth, healthcare providers manage the condition as an oral cancer. [QUOTE="mbellar, post: 509227, member: 180067"] Alerts and Notices Synopsis Cutaneous squamous cell carcinoma in situ (SCCis), also known as Bowen disease, is defined histopathologically by malignant keratinocytes that involve the full thickness of the epidermis. Subject to the terms and conditions contained in this Agreement, you, your employees and agents are authorized to use CDT only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. can we bill dx M54.42 and M51.16 together? Copyright © 2022, the American Hospital Association, Chicago, Illinois. License to use CDT for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Check out the dx block of D04.4. [*]Carcinoma in situ of skin of s [QUOTE="thomas7331, post: 478231, member: 5404"] HPV-related oropharyngeal squamous cell carcinoma (OPSCC) is associated with a favorable prognosis, yet patients of color and low socioeconomic status (SES) continue to experience inferior outcomes. that coverage is not influenced by Revenue Code and the article should be assumed to apply equally to all Revenue Codes. Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license. The Table of Neoplasms should be used to identify the correct topography code. You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. The American Hospital Association ("the AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service[s]). Current Dental Terminology © 2022 American Dental Association. SCCs often occur on the sun-exposed areas of the body, such as the rim of the ear, lower lip, face, bald scalp, neck, hands, arms, and legs. article does not apply to that Bill Type. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. This First Coast Billing and Coding Article for Local Coverage Determination (LCD) L33818 Excision of Malignant Skin Lesions provides billing and coding guidance for frequency limitations as well as diagnosis limitations that support diagnosis to procedure code automated denials. For example, 173.22:Squamous cell carcinoma of the skin of the ear and external auditory canal. All neoplasms are classified in this chapter, whether they are functionally active or not. CPT is a trademark of the American Medical Association (AMA). The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in the LCD. Treatment can involve surgical and nonsurgical methods. For purpose of this exclusion, "the term 'usually' means more than 50 percent of the time for all Medicare beneficiaries who use the drug. Noninvasive can be used as a synonym for in situ, ICD-O-3 behavior code /2. The American Hospital Association ("the AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. An official website of the United States government. It is important to remember when accessing the Neoplasm Table, to look under the main term Skin, first, then drop to the body part, to locate the appropriate code. If you would like to extend your session, you may select the Continue Button. In most instances Revenue Codes are purely advisory. Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, Please enable "JavaScript" and revisit this page or proceed with browsing CMS.gov with Chemical exposures, such as arsenic in drinking water, tar, or working with insecticides or herbicides. Use is limited to use in Medicare, Medicaid or other programs administered by the Centers for Medicare and Medicaid Services (CMS). End User License Agreement: However, please note that once a group is collapsed, the browser Find function will not find codes in that group. Request a Demo 14 Day Free Trial Buy Now Official Long Descriptor Carcinoma in situ of skin Excludes1: erythroplasia of Queyrat (penis) NOS ( D07.4) The AMA does not directly or indirectly practice medicine or dispense medical services. All those not listed under the ICD-10 Codes that Support Medical Necessity section of this article. AHA copyrighted materials including the UB‐04 codes and Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes. Applicable Federal Acquisition Regulation Clauses (FARS)/Department of Defense Federal Acquisition Regulation supplement (DFARS) Restrictions Apply to Government Use. This case is reportable because there are foci of intraepithelial carcinoma (carcinoma in situ). CMS believes that the Internet is Response to Comment (RTC) articles list issues raised by external stakeholders during the Proposed LCD comment period. American Hospital Association ("AHA"), Carcinoma in situ of skin of eyelid, including canthus, Carcinoma in situ of skin of ear and external auricular canal, Carcinoma in situ of skin of other and unspecified parts of face, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of skin of upper limb, including shoulder, Carcinoma in situ of skin of lower limb, including hip. The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 17260, 17261, 17262, 17263, 17264, 17266, 17270, 17271, 17272, 17273, 17274, 17276, 17280, 17281, 17282, 17283, 17284, 17286. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service[s]). Copyright © 2022, the American Hospital Association, Chicago, Illinois. hb```@( f p,&}5y5LJ"%%%3th/ $84C@1(6H(\Fed 6#V3gYq how would you code the excessive bleeding from SCC of the left side of nose and most of the left cheek? This common malignancy is primarily seen in older adults and most frequently occurs on sun-exposed skin. The AMA is a third party beneficiary to this Agreement. Example 1: A patient returns to the dermatologist to discuss removal of his SCC on his lower lip. End User Point and Click Amendment: To submit a comment or question to CMS, please use the Feedback/Ask a Question link available at the bottom C44.02 Squamous cell carcinoma of skin of lip CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. AHA copyrighted materials including the UB‐04 codes and C34 Malignant neoplasm of the bronchi and lung. Applications are available at the AMA Web site, http://www.ama-assn.org/go/cpt. The AMA assumes no liability for data contained or not contained herein. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. C44.22- Squamous cell carcinoma of skin of ear and external auricular canal The program covers drugs that are furnished "incident-to" a physician's service provided that the drugs are not "usually self-administered" by the patient. When verrucous carcinoma forms on your feet, they manage it as a skin cancer. D04.10 Carcinoma in situ of skin of unspecified eyelid, including canthus D04.111 Carcinoma in situ of skin of right upper eyelid, including . [LIST] Complete absence of all Bill Types indicates Primary squamous-cell carcinoma of the thyroid shows an aggressive biological phenotype . When a lesion is excised that is a neoplasm of uncertain morphology (e.g., melanoma vs. dyplastic nevi), choose the correct CPT code based on the manner in which the lesion is excised rather than the final pathological diagnosis. The responsibility for the content of this file/product is with CMS and no endorsement by the AMA is intended or implied. Squamous cell carcinoma of skin of lip C44.09 . You can use your browser's Print function (Ctrl-P on a PC or Command-P on a Mac) to view a print preview and then select PDF as the output. The Centers for Medicare & Medicaid Services (CMS), the federal agency responsible for administration of the Medicare, C and E treatment involves removing the surface of the skin cancer with a scraping instrument (curet) and then searing the base of the cancer with an electric needle. damages arising out of the use of such information, product, or process. Any questions pertaining to the license or use of the CPT should be addressed to the AMA. The 2023 edition of ICD-10-CM C44.52 became effective on October 1, 2022. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, L33818 - Excision of Malignant Skin Lesions, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER OVER 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER OVER 4.0 CM, Malignant melanoma of other part of trunk, Malignant melanoma of unspecified upper limb, including shoulder, Malignant melanoma of right upper limb, including shoulder, Malignant melanoma of left upper limb, including shoulder, Malignant melanoma of unspecified lower limb, including hip, Malignant melanoma of right lower limb, including hip, Malignant melanoma of left lower limb, including hip, Merkel cell carcinoma of other part of trunk, Merkel cell carcinoma of unspecified upper limb, including shoulder, Merkel cell carcinoma of right upper limb, including shoulder, Merkel cell carcinoma of left upper limb, including shoulder, Merkel cell carcinoma of unspecified lower limb, including hip, Merkel cell carcinoma of right lower limb, including hip, Merkel cell carcinoma of left lower limb, including hip, Unspecified malignant neoplasm of anal skin, Unspecified malignant neoplasm of skin of breast, Unspecified malignant neoplasm of skin of other part of trunk, Basal cell carcinoma of skin of other part of trunk, Squamous cell carcinoma of skin of breast, Squamous cell carcinoma of skin of other part of trunk, Other specified malignant neoplasm of anal skin, Other specified malignant neoplasm of skin of breast, Other specified malignant neoplasm of skin of other part of trunk, Unspecified malignant neoplasm of skin of unspecified upper limb, including shoulder, Unspecified malignant neoplasm of skin of right upper limb, including shoulder, Unspecified malignant neoplasm of skin of left upper limb, including shoulder, Basal cell carcinoma of skin of unspecified upper limb, including shoulder, Basal cell carcinoma of skin of right upper limb, including shoulder, Basal cell carcinoma of skin of left upper limb, including shoulder, Squamous cell carcinoma of skin of unspecified upper limb, including shoulder, Squamous cell carcinoma of skin of right upper limb, including shoulder, Squamous cell carcinoma of skin of left upper limb, including shoulder, Other specified malignant neoplasm of skin of unspecified upper limb, including shoulder, Other specified malignant neoplasm of skin of right upper limb, including shoulder, Other specified malignant neoplasm of skin of left upper limb, including shoulder, Unspecified malignant neoplasm of skin of unspecified lower limb, including hip, Unspecified malignant neoplasm of skin of right lower limb, including hip, Unspecified malignant neoplasm of skin of left lower limb, including hip, Basal cell carcinoma of skin of unspecified lower limb, including hip, Basal cell carcinoma of skin of right lower limb, including hip, Basal cell carcinoma of skin of left lower limb, including hip, Squamous cell carcinoma of skin of unspecified lower limb, including hip, Squamous cell carcinoma of skin of right lower limb, including hip, Squamous cell carcinoma of skin of left lower limb, including hip, Other specified malignant neoplasm of skin of unspecified lower limb, including hip, Other specified malignant neoplasm of skin of right lower limb, including hip, Other specified malignant neoplasm of skin of left lower limb, including hip, Malignant neoplasm of unspecified upper limb, Malignant neoplasm of unspecified lower limb, Malignant neoplasm of other specified ill-defined sites, Melanoma in situ of breast (skin) (soft tissue), Melanoma in situ of unspecified upper limb, including shoulder, Melanoma in situ of right upper limb, including shoulder, Melanoma in situ of left upper limb, including shoulder, Melanoma in situ of unspecified lower limb, including hip, Melanoma in situ of right lower limb, including hip, Melanoma in situ of left lower limb, including hip, Carcinoma in situ of skin of unspecified upper limb, including shoulder, Carcinoma in situ of skin of right upper limb, including shoulder, Carcinoma in situ of skin of left upper limb, including shoulder, Carcinoma in situ of skin of unspecified lower limb, including hip, Carcinoma in situ of skin of right lower limb, including hip, Carcinoma in situ of skin of left lower limb, including hip, Unspecified malignant neoplasm of skin of scalp and neck, Basal cell carcinoma of skin of scalp and neck, Squamous cell carcinoma of skin of scalp and neck, Other specified malignant neoplasm of skin of scalp and neck, Malignant neoplasm of overlapping sites of vulva, Malignant neoplasm of other specified female genital organs, Malignant neoplasm of overlapping sites of female genital organs, Malignant neoplasm of overlapping sites of penis, Malignant neoplasm of head, face and neck, Secondary malignant neoplasm of genital organs, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of unspecified female genital organs, Carcinoma in situ of other female genital organs, Carcinoma in situ of unspecified male genital organs, Carcinoma in situ of other male genital organs, Malignant neoplasm of external lip, unspecified, Malignant neoplasm of upper lip, inner aspect, Malignant neoplasm of lower lip, inner aspect, Malignant neoplasm of lip, unspecified, inner aspect, Malignant neoplasm of commissure of lip, unspecified, Malignant neoplasm of overlapping sites of lip, Malignant neoplasm of dorsal surface of tongue, Malignant neoplasm of ventral surface of tongue, Malignant neoplasm of anterior two-thirds of tongue, part unspecified, Malignant neoplasm of overlapping sites of tongue, Malignant neoplasm of tongue, unspecified, Malignant neoplasm of anterior floor of mouth, Malignant neoplasm of lateral floor of mouth, Malignant neoplasm of overlapping sites of floor of mouth, Malignant neoplasm of floor of mouth, unspecified, Malignant neoplasm of overlapping sites of palate, Malignant neoplasm of palate, unspecified, Malignant neoplasm of overlapping sites of unspecified parts of mouth, Malignant neoplasm of overlapping sites of other parts of mouth, Malignant neoplasm of submandibular gland, Malignant neoplasm of major salivary gland, unspecified, Malignant neoplasm of tonsillar pillar (anterior) (posterior), Malignant neoplasm of overlapping sites of tonsil, Malignant neoplasm of tonsil, unspecified, Malignant neoplasm of anterior surface of epiglottis, Malignant neoplasm of lateral wall of oropharynx, Malignant neoplasm of posterior wall of oropharynx, Malignant neoplasm of overlapping sites of oropharynx, Malignant neoplasm of oropharynx, unspecified, Malignant neoplasm of superior wall of nasopharynx, Malignant neoplasm of posterior wall of nasopharynx, Malignant neoplasm of lateral wall of nasopharynx, Malignant neoplasm of anterior wall of nasopharynx, Malignant neoplasm of overlapping sites of nasopharynx, Malignant neoplasm of nasopharynx, unspecified, Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect, Malignant neoplasm of posterior wall of hypopharynx, Malignant neoplasm of overlapping sites of hypopharynx, Malignant neoplasm of hypopharynx, unspecified, Malignant neoplasm of pharynx, unspecified, Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx, Malignant melanoma of unspecified eyelid, including canthus, Malignant melanoma of right upper eyelid, including canthus, Malignant melanoma of right lower eyelid, including canthus, Malignant melanoma of left upper eyelid, including canthus, Malignant melanoma of left lower eyelid, including canthus, Malignant melanoma of unspecified ear and external auricular canal, Malignant melanoma of right ear and external auricular canal, Malignant melanoma of left ear and external auricular canal, Malignant melanoma of unspecified part of face, Malignant melanoma of other parts of face, Malignant melanoma of overlapping sites of skin, Merkel cell carcinoma of unspecified eyelid, including canthus, Merkel cell carcinoma of right upper eyelid, including canthus, Merkel cell carcinoma of right lower eyelid, including canthus, Merkel cell carcinoma of left upper eyelid, including canthus, Merkel cell carcinoma of left lower eyelid, including canthus, Merkel cell carcinoma of unspecified ear and external auricular canal, Merkel cell carcinoma of right ear and external auricular canal, Merkel cell carcinoma of left ear and external auricular canal, Merkel cell carcinoma of unspecified part of face, Merkel cell carcinoma of other parts of face, Merkel cell carcinoma of overlapping sites, Unspecified malignant neoplasm of skin of lip, Other specified malignant neoplasm of skin of lip, Unspecified malignant neoplasm of skin of unspecified eyelid, including canthus, Unspecified malignant neoplasm of skin of right upper eyelid, including canthus, Unspecified malignant neoplasm of skin of right lower eyelid, including canthus, Unspecified malignant neoplasm of skin of left upper eyelid, including canthus, Unspecified malignant neoplasm of skin of left lower eyelid, including canthus, Basal cell carcinoma of skin of unspecified eyelid, including canthus, Basal cell carcinoma of skin of right upper eyelid, including canthus, Basal cell carcinoma of skin of right lower eyelid, including canthus, Basal cell carcinoma of skin of left upper eyelid, including canthus, Basal cell carcinoma of skin of left lower eyelid, including canthus, Squamous cell carcinoma of skin of unspecified eyelid, including canthus, Squamous cell carcinoma of skin of right upper eyelid, including canthus, Squamous cell carcinoma of skin of right lower eyelid, including canthus, Squamous cell carcinoma of skin of left upper eyelid, including canthus, Squamous cell carcinoma of skin of left lower eyelid, including canthus, Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus, Sebaceous cell carcinoma of skin of right upper eyelid, including canthus, Sebaceous cell carcinoma of skin of right lower eyelid, including canthus, Sebaceous cell carcinoma of skin of left upper eyelid, including canthus, Sebaceous cell carcinoma of skin of left lower eyelid, including canthus, Other specified malignant neoplasm of skin of unspecified eyelid, including canthus, Other specified malignant neoplasm of skin of right upper eyelid, including canthus, Other specified malignant neoplasm of skin of right lower eyelid, including canthus, Other specified malignant neoplasm of skin of left upper eyelid, including canthus, Other specified malignant neoplasm of skin of left lower eyelid, including canthus, Unspecified malignant neoplasm of skin of unspecified ear and external auricular canal, Unspecified malignant neoplasm of skin of right ear and external auricular canal, Unspecified malignant neoplasm of skin of left ear and external auricular canal, Basal cell carcinoma of skin of unspecified ear and external auricular canal, Basal cell carcinoma of skin of right ear and external auricular canal, Basal cell carcinoma of skin of left ear and external auricular canal, Squamous cell carcinoma of skin of unspecified ear and external auricular canal, Squamous cell carcinoma of skin of right ear and external auricular canal, Squamous cell carcinoma of skin of left ear and external auricular canal, Other specified malignant neoplasm of skin of unspecified ear and external auricular canal, Other specified malignant neoplasm of skin of right ear and external auricular canal, Other specified malignant neoplasm of skin of left ear and external auricular canal, Unspecified malignant neoplasm of skin of unspecified part of face, Unspecified malignant neoplasm of skin of nose, Unspecified malignant neoplasm of skin of other parts of face, Basal cell carcinoma of skin of unspecified parts of face, Basal cell carcinoma of skin of other parts of face, Squamous cell carcinoma of skin of unspecified parts of face, Squamous cell carcinoma of skin of other parts of face, Other specified malignant neoplasm of skin of unspecified parts of face, Other specified malignant neoplasm of skin of nose, Other specified malignant neoplasm of skin of other parts of face, Unspecified malignant neoplasm of overlapping sites of skin, Basal cell carcinoma of overlapping sites of skin, Squamous cell carcinoma of overlapping sites of skin, Other specified malignant neoplasm of overlapping sites of skin, Carcinoma in situ of oral cavity, unspecified site, Carcinoma in situ of labial mucosa and vermilion border, Carcinoma in situ of gingiva and edentulous alveolar ridge, Melanoma in situ of unspecified eyelid, including canthus, Melanoma in situ of right upper eyelid, including canthus, Melanoma in situ of right lower eyelid, including canthus, Melanoma in situ of left upper eyelid, including canthus, Melanoma in situ of left lower eyelid, including canthus, Melanoma in situ of unspecified ear and external auricular canal, Melanoma in situ of right ear and external auricular canal, Melanoma in situ of left ear and external auricular canal, Melanoma in situ of unspecified part of face, Carcinoma in situ of skin of unspecified eyelid, including canthus, Carcinoma in situ of skin of right upper eyelid, including canthus, Carcinoma in situ of skin of right lower eyelid, including canthus, Carcinoma in situ of skin of left upper eyelid, including canthus, Carcinoma in situ of skin of left lower eyelid, including canthus, Carcinoma in situ of skin of unspecified ear and external auricular canal, Carcinoma in situ of skin of right ear and external auricular canal, Carcinoma in situ of skin of left ear and external auricular canal, Carcinoma in situ of skin of unspecified part of face, Carcinoma in situ of skin of other parts of face, Some older versions have been archived.